Literature DB >> 22192170

Vitamin D and its role in allergic disease.

M Reinholz1, T Ruzicka, J Schauber.   

Abstract

In Western countries, the incidence of atopy and allergic diseases is high and further rising. While genetic factors certainly play a role, epigenetic or even nutritional factors might also be important in the pathogenesis of allergies. Vitamin D - the 'sunshine hormone' - exerts profound effects on both adaptive and innate immune functions involved in the development and course of allergic diseases. As also the incidence of vitamin D insufficiency is surprisingly high in the general population, clinical and experimental studies have started to investigate if correcting vitamin D levels [measured as serum 25 hydroxy vitamin D -25(OH)D] is beneficial or even protective in patients with allergies or children at risk. This review highlights current data on the effects of vitamin D on the allergy-mediating immune system and the vitamin D status in atopic patients. Furthermore, the benefits and risks of vitamin D supplementation during pregnancy, childhood and in adults with respect to the development and course of allergic disease are discussed.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22192170     DOI: 10.1111/j.1365-2222.2011.03923.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  11 in total

Review 1.  Modified allergens and their potential to treat allergic disease.

Authors:  Laurian Jongejan; Ronald van Ree
Journal:  Curr Allergy Asthma Rep       Date:  2014-12       Impact factor: 4.806

2.  Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model.

Authors:  T Agrawal; G K Gupta; D K Agrawal
Journal:  Clin Exp Allergy       Date:  2013-06       Impact factor: 5.018

Review 3.  Vitamin D and the development of allergic disease: how important is it?

Authors:  H Mirzakhani; A Al-Garawi; S T Weiss; A A Litonjua
Journal:  Clin Exp Allergy       Date:  2015-01       Impact factor: 5.018

4.  The Effect of Serum Vitamin D Level on Allergic Rhinitis Symptoms in Children.

Authors:  Zeynep Haziroglu Okmen; Mehmet Halil Celiksoy; Erdem Topal
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2021-12       Impact factor: 1.349

5.  Vitamin D serum levels in children with allergic and vasomotor rhinitis.

Authors:  Seung Jin Lee; Bong Hwa Kang; Bong Seok Choi
Journal:  Korean J Pediatr       Date:  2015-09-21

6.  Longitudinal trajectory of vitamin D status from birth to early childhood in the development of food sensitization.

Authors:  Xin Liu; Lester Arguelles; Ying Zhou; Guoying Wang; Qi Chen; Hui-Ju Tsai; Xiumei Hong; Rong Liu; Heather E Price; Colleen Pearson; Stephanie Apollon; Natalie Cruz; Robert Schleimer; Craig B Langman; Jacqueline A Pongracic; Xiaobin Wang
Journal:  Pediatr Res       Date:  2013-06-24       Impact factor: 3.756

7.  25-Hydroxyvitamin D, IL-31, and IL-33 in children with allergic disease of the airways.

Authors:  Anna Bonanno; Sebastiano Gangemi; Stefania La Grutta; Velia Malizia; Loredana Riccobono; Paolo Colombo; Fabio Cibella; Mirella Profita
Journal:  Mediators Inflamm       Date:  2014-06-26       Impact factor: 4.711

8.  World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Vitamin D.

Authors:  Alessandro Fiocchi; Ruby Pawankar; Juan José Yepes-Nuñez; Carlos A Cuello-Garcia; Yuan Zhang; Gian Paolo Morgano; Kangmo Ahn; Suleiman Al-Hammadi; Arnav Agarwal; Shreyas Gandhi; Kirsten Beyer; Wesley Burks; Giorgio W Canonica; Motohiro Ebisawa; Rose Kamenwa; Bee Wah Lee; Haiqi Li; Susan Prescott; John J Riva; Lanny Rosenwasser; Hugh Sampson; Michael Spigler; Luigi Terracciano; Andrea Vereda; Susan Waserman; Holger J Schünemann; Jan L Brożek
Journal:  World Allergy Organ J       Date:  2016-05-17       Impact factor: 4.084

9.  Towards evidence-based vitamin D supplementation in infants: vitamin D intervention in infants (VIDI) - study design and methods of a randomised controlled double-blinded intervention study.

Authors:  Otto Helve; Heli Viljakainen; Elisa Holmlund-Suila; Jenni Rosendahl; Helena Hauta-Alus; Maria Enlund-Cerullo; Saara Valkama; Kati Heinonen; Katri Räikkönen; Timo Hytinantti; Outi Mäkitie; Sture Andersson
Journal:  BMC Pediatr       Date:  2017-03-29       Impact factor: 2.125

10.  Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease.

Authors:  Markus Reinholz; Thomas Ruzicka; Jürgen Schauber
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.